Tag: SYMPHONY-PE
SYMPHONY-PE analysis finds early thrombectomy improves recovery in intermediate-risk PE
Imperative Care has announced findings from a post-hoc analysis of the SYMPHONY-PE trial evaluating the effect of early mechanical thrombectomy in patients with intermediate-risk...
Imperative Care receives US FDA 510(k) clearance for Symphony thrombectomy system
Imperative Care today announced US Food and Drug Administration (FDA) 510(k) clearance of its Symphony thrombectomy system to treat pulmonary embolism (PE).
This clearance expands the...
Imperative Care announces completion of enrolment in the SYMPHONY-PE study
Imperative Care today announced the completion of patient enrolment in its SYMPHONY-PE study, a pivotal investigational device exemption (IDE) trial evaluating the safety and...